Neuroimaging & Brain Measures5-MeO-DMT

Exploring 5-MeO-DMT as a pharmacological model for deconstructed consciousness

In an exploratory observational study using micro-phenomenological interviews, psychometric questionnaires and EEG in naturalistic ceremonial settings, the authors show that 5‑MeO‑DMT can produce a progressive deconstruction of selfhood — in extreme cases a complete absence of self-experience and other phenomenal content with preserved awareness — accompanied by global alpha and posterior beta power reductions consistent with inhibition of top‑down models. The findings support 5‑MeO‑DMT as a pharmacological model for deconstructed consciousness while noting methodological limitations and the need for controlled, real‑time and phenomenologically trained studies.

Authors

  • Robin Carhart-Harris
  • Christopher Timmermann
  • David Erritzoe

Published

Neuroscience of Consciousness
individual Study

Abstract

5-MeO-DMT is a short-acting psychedelic that is anecdotally reported to induce a radical disruption of the self and a paradoxical quality of aroused, waking awareness that is nevertheless devoid of any specific perceptual contents. Here, we conducted an exploratory observational study of the phenomenological and neuronal effects of this compound. We collected micro-phenomenological interviews, psychometric questionnaires, and electroencephalography (EEG) in naturalistic ceremonial settings where 5-MeO-DMT was ingested. Results revealed that the 5-MeO-DMT experience followed a dynamic progression that—only in the most extreme cases—manifested as a complete absence of self-experience and other phenomenal content with preserved awareness. Furthermore, visual imagery, bodily self-disruption, narrative self-disruption, and reduced phenomenal distinctions occurred in a variable fashion. EEG analyses revealed the 5-MeO-DMT experience was characterised by (global) alpha and (posterior) beta power reductions, implying a mode of brain functioning where top-down models are inhibited. Our preliminary phenomenological findings confirm the potential utility of 5-MeO-DMT as a pharmacological model for deconstructed consciousness while noting the limitations of employing retrospective questionnaires for this purpose. Considering the exploratory nature of this study and its limitations inherent to its naturalistic nature, further research employing real-time experience sampling and phenomenologically trained participants in controlled environments could expand our findings to meaningfully inform the potential of this tool for the scientific study of consciousness.

Available with Blossom Pro

Research Summary of 'Exploring 5-MeO-DMT as a pharmacological model for deconstructed consciousness'

Introduction

Psychedelics offer a means to perturb conscious experience while preserving wakefulness, making them useful for studying mechanisms of consciousness. Timmermann and colleagues note that 5-MeO-DMT is pharmacologically atypical among classic psychedelics: although it acts at 5-HT2A receptors, preliminary reports point to unusually rapid and potent disruption of self-related processing with comparatively less visual imagery, possibly related to higher 5-HT1A agonism. Anecdotal reports describe peak 5-MeO-DMT states as a ‘‘void’’ or ‘‘nondual’’ experience in which selfhood and ordinary phenomenal contents are profoundly diminished despite preserved arousal, a profile that could be informative about the minimal constituents of subjectivity or a ‘‘minimal phenomenal experience.’' This study set out to perform an exploratory neurophenomenological investigation of 5-MeO-DMT in naturalistic ceremonial settings. The investigators combined micro-phenomenological interviews (MPIs), retrospective psychometric questionnaires (the Altered States of Consciousness, ASC, questionnaire), and electroencephalography (EEG) to characterise time-dependent phenomenology and concurrent brain activity. The primary hypothesis was that 5-MeO-DMT would disrupt multiple aspects of the sense of self and reduce alpha-band power in EEG. The paper emphasises the need for rigorous first-person methods (MPIs) to mitigate confabulation and improve the temporal precision of subjective reports when studying extreme psychedelic states.

Expert Research Summaries

Go Pro to access AI-powered section-by-section summaries, editorial takes, and the full research toolkit.

Full Text PDF

Full Paper PDF

Create a free account to open full-text PDFs.

Study Details

References (13)

Papers cited by this study that are also in Blossom

REBUS and the Anarchic Brain: Toward a Unified Model of the Brain Action of Psychedelics

Carhart-Harris, R. L., Friston, K. J. · Pharmacological Reviews (2019)

The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs

Carhart-Harris, R. L., Leech, R., Shanahan, M. et al. · Frontiers in Human Neuroscience (2014)

A narrative synthesis of research with 5-MeO-DMT

Ermakova, A. O., Dunbar, F., Rucker, J. et al. · Journal of Psychopharmacology (2021)

Exploring mechanisms of psychedelic action using neuroimaging

Erritzoe, D., Timmermann, C., Godfrey, K. et al. · Nature Mental Health (2024)

28 cited
The kappa opioid receptor and the sleep of reason: Cortico-subcortical imbalance following salvinorin-A

Ona, G., Sampedro, F., Romero, S. et al. · International Journal of Neuropsychopharmacology (2021)

Neural and subjective effects of inhaled N,N-dimethyltryptamine in natural settings

Pallavicini, C., Cavanna, F., Zamberlan, F. et al. · Journal of Psychopharmacology (2021)

Quality of acute psychedelic experience predicts therapeutic efficacy of psilocybin for treatment-resistant depression

Roseman, L., Nutt, D. J., Carhart-Harris, R. L. · Frontiers in Pharmacology (2018)

Psychometric evaluation of the altered states of consciousness rating scale (OAV)

Studerus, E., Gamma, A., Vollenweider, F. X. · PLOS ONE (2010)

Human brain effects of DMT assessed via EEG-fMRI

Timmermann, C., Roseman, L., Haridas, S. et al. · PNAS (2023)

158 cited
Show all 13 references
Neural correlates of the DMT experience assessed with multivariate EEG

Timmermann, C., Roseman, L., Schartner, M. et al. · Scientific Reports (2019)

Cited By (1)

Papers in Blossom that reference this study

DMT micro-phenomenology

Sanders, J. W., Milliere, R., Daily, Z. G. et al. · Preprints (2024)

Your Personal Research Library

Go Pro to save papers, add notes, rate studies, and organize your research into custom shelves.